# Safety and Preliminary Efficacy of Hibernation-Like Therapy (Chlorpromazine and Promethazine) in Patients With Acute Ischemic Stroke (AIS) Eligible for Reperfusion Therapy.

> **NCT07364344** · NA · NOT_YET_RECRUITING · sponsor: **Ji Xunming,MD,PhD** · enrollment: 57 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Hibernation-like Therapy (Chlorpromazine and Promethazine, C+P)

## Key facts

- **NCT ID:** NCT07364344
- **Lead sponsor:** Ji Xunming,MD,PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2026-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07364344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07364344, "Safety and Preliminary Efficacy of Hibernation-Like Therapy (Chlorpromazine and Promethazine) in Patients With Acute Ischemic Stroke (AIS) Eligible for Reperfusion Therapy.". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07364344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*